{"name": "Medgenics",
 "permalink": "medgenics",
 "crunchbase_url": "http://www.crunchbase.com/company/medgenics",
 "homepage_url": "http://www.medgenics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@medgenics.com",
 "phone_number": "646-239-1690",
 "description": "",
 "created_at": "Thu Feb 17 13:39:13 UTC 2011",
 "updated_at": "Thu Feb 17 13:43:04 UTC 2011",
 "overview": "\u003Cp\u003EMedgenics is a clinical-stage biopharmaceutical company developing an innovative and proprietary platform technology - a biological \u0026#8220;Biopump\u0026#8221; - which allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       61],
      "assets/images/resized/0012/2566/122566v1-max-150x150.jpg"],
     [[230,
       94],
      "assets/images/resized/0012/2566/122566v1-max-250x250.jpg"],
     [[230,
       94],
      "assets/images/resized/0012/2566/122566v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "8000 Towers Crescent Dr.",
    "address2": "Suite 1300",
    "zip_code": "22182",
    "city": "Vienna",
    "state_code": "VA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Medgenics Sees Shares, Warrants Pricing At $5-$7 In US IPO",
    "stoned_year": 2011,
    "stoned_month": 2,
    "stoned_day": 17,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020110217e72h0008d\u0026r=Rss\u0026s=DJFVLS",
    "source_text": "",
    "source_description": "Medgenics Sees Shares, Warrants Pricing At $5-$7 In US IPO",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Medgenics",
      "permalink": "medgenics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        130],
       "assets/images/resized/0012/2567/122567v1-max-150x150.jpg"],
      [[250,
        218],
       "assets/images/resized/0012/2567/122567v1-max-250x250.jpg"],
      [[450,
        392],
       "assets/images/resized/0012/2567/122567v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}